immunotherapy

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

immunotherapy
Jun 21, 2025, 16:28 | Science
Yan Leyfman: Practice-Changing Data in Head and Neck Cancer
Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post on LinkedIn: "Practice-Changing…
Jun 21, 2025, 14:00 | Science
Julien Taieb: Early ctDNA and Survival in Metastatic Colorectal Cancer Treated With ICIs
Julien Taieb, Professor at Paris Descartes University, shared a post on LinkedIn about a paper…
Jun 21, 2025, 11:07 | Insight
ASCO 2025 RCC Advances: Expert Insights by Ilya Tsimafeyeu
The 2025 ASCO Annual Meeting in Chicago showcased transformative developments in renal cell carcinoma (RCC),…
Jun 19, 2025, 15:50 | Science
Alexey Kulikov Shared An Article on Cancer Vaccines and The Future of Immunotherapy
Alexey Kulikov, Head of Partnerships and Operations, Deputy Head of Secretariat for the UN NCD…
Jun 19, 2025, 13:13 | Oncolibrary
New Paper Alert: KEYNOTE-689. Neoadjuvant and Adjuvant Pembrolizumab Improves Survival in Locally Advanced HNC
KEYNOTE-689 trial,published in The New England Journal of Medicine on June 18, 2025, offers a…
Jun 19, 2025, 13:01 | Oncolibrary
Pancreatic Cancer Remission Rate: What Patients Should Know in 2025
Pancreatic cancer is often considered one of the most challenging malignancies in oncology, but recent…
Jun 19, 2025, 08:39 | Insight
Charles Jiang: Fascinating Insights on Timing of Checkpoint Inhibitor Infusions from ASCO25
Charles Jiang, Medical Oncologist at UT Southwestern, shared a post on X: "Still digesting all…
Jun 19, 2025, 04:29 | Oncolibrary
Bladder Cancer Cure Rate: What Patients Need to Know in 2025
Understanding the bladder cancer cure rate is crucial for patients and caregivers navigating this common…
Jun 17, 2025, 08:34 | Insight
Katsuaki Maehara Shared an Article Published in Signal Transduction and Targeted Therapy on Molecular Pathology and Therapy of NSCLC
Katsuaki Maehara, Director of Medical Education Colleagues, shared on X: "Advances in molecular pathology and…
Jun 17, 2025, 02:22 | Opinion
Yan Leyfman: Keynote Address on PD-1/PD-L1 Inhibitors at the 2025 Frontiers in Cancer Immunotherapy Symposium
Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post on LinkedIn: "Great…
Jun 15, 2025, 14:48 | Blog
Hung Trinh: BioNTech and Bristol Myers Squibb Partner on $11.1 Billion Cancer Immunotherapy Deal
Hung Trinh, Senior Director of Business Development at OBiO Tech and Senior VP of Operations…
Jun 14, 2025, 09:02 | Insight
Luca Arecco: Gonadotoxicity of immunotherapy and targeted agents in patients with cancer and impact on subsequent pregnancies
Luca Arecco, Clinical Research Fellow at ESMO, shared a post on X: "In the era…
Jun 14, 2025, 03:27 | Blog
Gerry Hanna: ESMO-ESTRO Framework for Radiotherapy and Systemic Therapy Safety
Gerry Hanna, Marie Curie Chair of Clinical Oncology at Trinity College Dublin, posted on X:…
Jun 13, 2025, 09:43 | Insight
Giuseppe Procopio: Current status of adiuvant immunotherapy in RCC
Giuseppe Procopio, Head of the Genitourinary Unit at Fondazione Istituto Nazionale Tumori, Milan, shared a…
Jun 12, 2025, 18:22 | Insight
Bruna Pellini: Chemotherapy Plus Anti-PD-1 or Anti-PD-L1 in Advanced PD-L1-Negative sqNSCLC
Bruna Pellini, Assistant Professor at the University of South Florida and Assistant Member of the…
Jun 12, 2025, 15:38 | Science
Adding Immunotherapy to Standard Chemotherapy Extends Quality of Life for Patients with Advanced Endometrial Cancer
A study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators found that combining the…
Jun 12, 2025, 09:45 | Blog
Ramy Sedhom: Novel Systemic Anticancer Treatments and Health Services Use at the End of Life Among Adults with Cancer
Ramy Sedhom, Clinical Director of Palliative Care at Penn Medicine Princeton Health, posted on X:…
Jun 11, 2025, 16:12 | Insight
Immunotherapy Plus Chemotherapy Before Surgery Improves Long-Term Survival in NSCLC - Johns Hopkins Medicine International
Johns Hopkins Medicine International shared a post on LinkedIn: "Adding immunotherapy to chemotherapy before surgery…
Jun 11, 2025, 11:22 | Blog
Join Society for Immunotherapy of Cancer from Nov. 5–9 to celebrate 40 years of driving breakthroughs in cancer IO
Society for Immunotherapy of Cancer shared a post on X: "Join us from Nov. 5–9…
Jun 10, 2025, 17:40 | Insight
ESTRO Shared Prospective Study on Immune Response to SBRT in Lung Metastases
ESTRO shared a post on X about a recent study published in Radiotherapy and Oncology:…
Jun 10, 2025, 16:27 | Blog
Timothée Olivier Shared His ASCO25 Talk
Timothée Olivier, Medical Oncologist at the Oncology Division of Geneva University Hospital in Switzerland, posted…
Jun 10, 2025, 10:03 | Science
Mario Mandalà: The Impact of SRT in Melanoma Patients with Brain Metastases Receiving Combo Immunotherapy
Mario Mandalà, Director of Medical Oncology at S.M. Misericordia Hospital and an Associate Professor of Medical…
Jun 10, 2025, 02:38 | Blog
Sami (Papacek) Mansfield: Should Exercise Be Prescribed Alongside Immunotherapy?
Sami (Papacek) Mansfield, Founder of Cancer Wellness for Life, shared a post on LinkedIn: "Should…
Jun 8, 2025, 11:03 | Blog
Caryn Lerman Highlights Promising Optune–Keytruda Combination in Glioblastoma Trial led by David Tran
Caryn Lerman, Director of USC Norris and the H. Leslie and Elaine S. Hoffman Professor in…
Jun 8, 2025, 06:46 | Blog
Eric Deutsch Will Host 9th ImmunoRad Conference in Paris
Eric Deutsch, Chair of the Radiation Therapy Department at the Gustave Roussy Cancer Institute, shared…
Jun 7, 2025, 16:30 | Insight
Goutham Sunny: Breakthroughs in Targeted Cancer Therapies
Goutham Sunny, Former Resident Doctor at The Gujarat Cancer and Research Institute, shared key highlights…
Jun 6, 2025, 16:15 | Insight
Yan Leyfman: IFN-γR Knockout Improves CD28 CAR T Cell Function in Tumor Models
Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post on LinkedIn: "New…
Jun 6, 2025, 07:49 | Blog
Vikash Dodhia: Mount Vernon Cancer Centre First in UK to Offer Immunotherapy Sub-Cutaneous Injection
Vikash Dodhia, Head of Pharmacy at East and North Hertfordshire NHS Trust, posted on LinkedIn:…
Jun 6, 2025, 07:30 | Blog
Apply For The 2026 SCION Workshop by August 7
Society for Immunotherapy of Cancer shared a post on X: "Apply for the 2026 SCION…
Jun 5, 2025, 15:07 | Insight
Praveen Kumar Marimuthu: Best of ASCO 2025 - LMIC version
Praveen Kumar Marimuthu, Assistant Professor of Medical Oncology at Christian Medical College and Hospital, shared…
Jun 5, 2025, 08:06 | Blog
Garo Armen on Agenus's Recent Partnership with Zydus Group to Advance Immunotherapy in India
Agenus shared a post on LinkedIn: "Hear from Agenus CEO Garo Armen on our recent…
Jun 5, 2025, 01:54 | Insight
Key Insights by Abner Antonio Murray from ASCO25
At  ASCO 2025 Annual Meeting, Abner Antonio Murray, Hematology/Oncology Fellow at UNC School of Medicine,…
Jun 4, 2025, 06:08 | Blog
Han Chong Toh Recaps ASCO 2025 Highlights in Immunotherapy and AI
Han Chong Toh, Deputy Chief Executive Officer at National Cancer Centre Singapore, shared a post…
Jun 4, 2025, 06:04 | Blog
Rebecca Shatsky on Working With Leadership to Prioritize Chair Time for Patients on ICIs
Rebecca Shatsky, Breast Cancer Medical Oncologist at UCSD, shared on X: "So what are we all going…
Jun 3, 2025, 18:18 | Insight
Elizabeth McKenna: Study on Vascular Normalization and Enhanced Immunotherapy
Elizabeth McKenna, Executive Editor of Cancer Discovery, shared a post on X about a paper…
Jun 3, 2025, 16:39 | Insight
Pashtoon Kasi: This Is the 1st Time I Started Hearing the Word “CURE” in Patients with Metastatic Stage-IV Cancers
Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope Orange County, shared…
Jun 3, 2025, 11:42 | Blog
Pashtoon Kasi Shares Immunotherapy Insights for MSS Colorectal Cancer at ASCO 2025
Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope Orange County, posted…
Jun 3, 2025, 07:47 | Blog
Brian Rini: ASCO25 Final Results of IO-based Combinations in mRCC are in
Brian Rini, Chief of Clinical Trials at Vanderbilt University, posted on X: "ASCO25 Final results…
Jun 2, 2025, 11:31 | Oncolibrary
FIRST/ENGOT-OV44 Trial Results at ASCO 2025: Dostarlimab Plus Niraparib Improves Progression-Free Survival in First-Line Advanced Ovarian Cancer
Presented at ASCO 2025 by Dr. Anne-Claire Hardy-Bessard, the FIRST/ENGOT-OV44 Phase III trial (NCT03602859) evaluated…
Jun 2, 2025, 05:43 | Oncolibrary
ctDNA Analysis in the Phase 3 NIAGARA Trial: Perioperative Durvalumab with Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
Muscle-invasive bladder cancer (MIBC) remains a high-risk disease with a substantial rate of recurrence despite…
Jun 2, 2025, 02:56 | Oncolibrary
CheckMate 577 Final Results: Adjuvant Nivolumab Sustains Disease-Free Survival Benefit in Resected Esophageal and Gastroesophageal Junction Cancer
Esophageal cancer (EC) and gastroesophageal junction cancer (GEJC) remain aggressive malignancies with poor prognosis, even…
Jun 1, 2025, 15:33 | Oncolibrary
NIVOPOSTOP Phase 3 Trial: Adding Nivolumab to Standard Chemoradiotherapy Improves Disease-Free Survival in High-Risk Resected LA-SCCHN
For more than two decades, the standard adjuvant treatment for patients with resected locally advanced…
Jun 1, 2025, 14:50 | Insight
Pashtoon Kasi Highlighted Study on Vilastobart (XTX101) + Atezolizumab in MSS Colorectal Cancer at ASCO 2025
Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope Orange County, shared…
Jun 1, 2025, 13:02 | Oncolibrary
CheckMate 214 Trial Final 9-Year Results at ASCO 2025: Nivolumab Plus Ipilimumab Continues to Show Long-Term Survival Benefit in Advanced Renal Cell Carcinoma
Presented by Dr. Robert J. Motzer at ASCO 2025, the final 9-year follow-up results from…
Jun 1, 2025, 11:24 | Oncolibrary
CheckMate 901 Trial Final Results at ASCO 2025: Nivolumab + Ipilimumab Shows Durable Responses in Cisplatin-Ineligible Metastatic Urothelial Carcinoma
Presented by Dr. Michiel S. Van Der Heijden (Netherlands Cancer Institute, Amsterdam) at the ASCO…
Jun 1, 2025, 10:41 | Oncolibrary
ATOMIC Trial Results at ASCO 2025: Atezolizumab Significantly Improves Disease-Free Survival in Stage III dMMR Colon Cancer
Standard adjuvant chemotherapy for stage III colon cancer typically involves fluoropyrimidine combined with oxaliplatin. For…
Jun 1, 2025, 03:12 | Oncolibrary
KEYNOTE-630 Phase 3 Trial at ASCO 2025: Adjuvant Pembrolizumab Does Not Significantly Improve Outcomes in High-Risk Resected Cutaneous Squamous Cell Carcinoma
Patients with high-risk locally advanced cutaneous squamous cell carcinoma (LA cSCC) face substantial risk of…
May 31, 2025, 18:39 | Blog
Pembrolizumab Helps Head and Neck Cancer Patients Live Years Longer Cancer-Free - The Institute of Cancer Research
The Institute of Cancer Research shared a post on LinkedIn: "BREAKING: Researchers at the ICR…
May 31, 2025, 10:22 | Oncolibrary
CheckMate 8HW Trial at ASCO 2025: Nivolumab Plus Ipilimumab Sets New Standard for MSI-H/dMMR Metastatic Colorectal Cancer
The phase 3 CheckMate 8HW study, presented at the ASCO 2025 annual meeting, delivers compelling…
May 31, 2025, 10:13 | Blog
Patrick Hwu: The Importance of Combination Immunotherapy Strategies in Overcoming Resistance at ASCO25
Patrick Hwu, President and CEO of the Moffitt Cancer Center, posted on X: "Also enjoyed…
May 29, 2025, 17:41 | Blog
Amol Akhade: Can Perioperative Immunotherapy Change Outcomes in Resectable Gastric/GEJ Cancer?
Amol Akhade, Consultant Medical Oncologist at the Suyog Cancer Clinics, shared a post on LinkedIn:…
May 29, 2025, 17:28 | Science
Praveen Kumar Marimuthu: RWD Shows NACT Plus Immunotherapy Nearly Doubles pCR in MIBC
Praveen Kumar Marimuthu, Assistant Professor of Medical Oncology at Christian Medical College and Hospital, shared…
May 29, 2025, 12:53 | Blog
Aleix Prat: Representing Both the Clínic Barcelona Comprehensive Cancer Center and Reveal Genomics at ASCO25
Aleix Prat, Director of the Cancer Institute at the Hospital Clinic of Barcelona, shared a post…
May 29, 2025, 12:19 | Blog
Agenus Addresses Rising Colorectal Cancer Rates in Younger Adults
Agenus shared a post on LinkedIn: "Colorectal cancer is being diagnosed in younger people—those under 50—at…
May 28, 2025, 13:21 | Insight
May is Cancer Research Month: Advancing Science, Saving Lives
Every May, we celebrate National Cancer Research Month, recognizing the lifesaving impact of cancer research…
May 28, 2025, 11:51 | Blog
Fiona Thistlethwaite - Pushing the Boundaries of Cancer Research and Personalised Medicine - MCRC
Manchester Cancer Research Centre shared a post on LinkedIn: "Alumni Spotlight: Professor Fiona Thistlethwaite. After finishing…
May 27, 2025, 12:16 | Blog
The Most Recent Articles from ESMOBreast25 on latest Developments in Breast Cancer
ESMO - European Society for Medical Oncology shared a post on LinkedIn: "Interested in the latest…
May 26, 2025, 08:09 | Blog
Luciano Costa: JNJ-5322 is Likely The Greatest Innovation We Have Seen in a Few Years
Luciano J Costa, Professor at University of Alabama at Birmingham, shared a post on X:…
May 26, 2025, 06:10 | Blog
Jason Mouabbi: Excitement is Building for ASCO25
Jason Mouabbi, Assistant professor of breast medical oncology at The University of Texas MD Anderson…
May 25, 2025, 14:50 | Insight
Kunal Jobanputra Shares Key Clinical Studies from ASCO 2025
Kunal Jobanputra, Community Medical Oncologist at Tata Memorial Hospital, shared some studies from ASCO 2025:…
May 25, 2025, 10:39 | Science
Marko Skelin: New Meta-Analysis on Immunotherapy’s Role in Treating Mesothelioma
Marko Skelin, Assistant Professor at University of Rijeka, shared an article on LinkedIn: "New Insights…
May 25, 2025, 06:24 | Blog
Bernard Fox: TIMO2025 - Great line-up of Immunotherapy Experts
Bernard Fox, Co-Founder, President and CEO of UbiVac, posted on X: "TIMO2025 Great line-up of…
May 24, 2025, 11:18 | Opinion
New Paper Alert: APOLLO Trial. Anlotinib Plus Penpulimab vs Sorafenib in First-Line Treatment of Unresectable Hepatocellular Carcinoma:
The APOLLO trial marks a significant advancement in the treatment landscape of unresectable hepatocellular carcinoma…
May 24, 2025, 06:16 | Oncolibrary
KEYNOTE-991 Trial Results: Pembrolizumab Plus Enzalutamide and ADT in mHSPC
KEYNOTE-991 is a pivotal phase III trial that explored whether adding pembrolizumab to enzalutamide and…
May 23, 2025, 12:45 | Cancer Center Near Me
Penn Medicine: Cancer Center Near Me
Founded in 1765, Penn Medicine is the nation’s first medical school and a leading academic…
May 23, 2025, 11:16 | Blog
John Gordon: SERT as a Novel Target in Cancer Immunotherapy via SSRIs
John Gordon, Co-Founder, Director and VP of Scientific Affairs at Celentyx, shared a post on LinkedIn:…
May 22, 2025, 14:18 | Cancer Types
Cholangiocarcinoma: Latest Risk Factors, Symptoms, Diagnosis, and 2025 Advanced Treatment Options for Bile Duct Cancer
This article provides an up-to-date, in-depth overview of cholangiocarcinoma (bile duct cancer) as of 2025.…
May 21, 2025, 11:58 | Science
Vivek Subbiah: Designing Clinical Trials for Patients With Rare Cancers
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared an…
May 20, 2025, 13:05 | Cancer Types
Pheochromocytoma: Causes, Diagnosis, Treatment, and Breakthrough 2025 Advances in Management
Pheochromocytoma is a rare adrenal tumor known for causing sudden spikes in blood pressure and…
May 20, 2025, 07:03 | Insight
David Gandara: Clinical and Biological Implications of Plasma Proteomics in NSCLC Presented at AACR 2025
David Gandara, Co-Director of the Center for Experimental Therapeutics at the UC Davis Comprehensive Cancer Center,…
May 19, 2025, 18:28 | Blog
Cancer treatment has evolved dramatically - FDA Oncology
FDA Oncology shared on X: "Cancer treatment has evolved dramatically! Then: Surgery and radiation were…
May 19, 2025, 13:41 | Oncolibrary,Opinion
New Paper Alert: NO LIMIT Trial. First-Line Nivolumab Plus Low-Dose Ipilimumab in MSI-High Advanced Gastric and GEJ Cancer
The NO LIMIT (WJOG13320G) Phase II trial investigates a novel, chemotherapy-free first-line approach using nivolumab…
May 19, 2025, 13:02 | Insight
Amol Akhade: New Development Therapeutic Data to Watch at ASCO 2025
Amol Akhade, Consultant Medical Oncologist at the Suyog Cancer Clinics, shared a post on LinkedIn:…
May 18, 2025, 11:49 | Blog
How Cancer Treatment Has Transformed with Modern Therapies - FDA Oncology
FDA Oncology shared a post on X: "Cancer treatment has evolved dramatically! Then, Surgery and…
May 18, 2025, 11:43 | Blog
Goutham Sunny: Immunotherapy in MSI-H Gastric Cancer - NO LIMIT trial
Goutham Sunny, Resident Doctor at The Gujarat Cancer and Research Institute, posted on X: "Immunotherapy…
May 17, 2025, 15:36 | Blog
Rasha Aboelhassan: Should we Give Chemotherapy with Immunotherapy as a Neoadjuvant Setting in stage I TNBC?
Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, shared a post on LinkedIn: "Elisabetta…
May 17, 2025, 02:12 | Blog
Inspiring Journey of the 2024 Yvonne Awardees — A Year of Impact and Leadership
In 2024, the Yvonne Awards honored a remarkable group of oncology leaders across diverse categories—from…
May 16, 2025, 13:21 | Oncolibrary
FDA Approves Retifanlimab-dlwr with Chemotherapy and as Monotherapy for Advanced Squamous Cell Carcinoma of the Anal Canal
On May 15, 2025, the U.S. Food and Drug Administration (FDA) approved retifanlimab-dlwr (Zynyz, Incyte…
May 16, 2025, 08:31 | Blog
Wafik S. El-Deiry: Karl Kelsey Presents on Immunotherapy Biomarkers in Head and Neck Cancer at Brown University
Wafik S. El-Deiry, Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and…
May 15, 2025, 15:08 | Science
Praveen Kumar Marimuthu: Preliminary Results with the Combo of Chemo, OMT and Low-Dose Nivo in Unresectable Oral Cancers
Praveen Kumar Marimuthu, DM Resident in Medical Oncology at the Christian Medical College and Hospital, reshared…
May 15, 2025, 10:23 | Blog
Highlights from ROME LUNG 25: A Global Gathering of Lung Cancer Experts
The 4th International Summit on Lung Cancer—ROME LUNG 25—was held on May 10–11, 2025, at…
May 13, 2025, 10:26 | Blog
Goutham Sunny: Economic Crisis Affected Access to Immunotherapy in Metastatic NSCLC
Goutham Sunny, Resident Doctor at The Gujarat Cancer and Research Institute, shared a post on X:…
May 11, 2025, 14:35 | Blog
Christian Rolfo: ADC in Combination with Immunotherapy in NSCLC by Stephen V Liu
Christian Rolfo, Division Director of Medical Oncology and Associate Director for Early Phase Clinical Trials at…
May 11, 2025, 13:58 | Blog
Domenico Galetta: Interesting and Intense Discussion on the Role of Neoadjuvant vs Perioperative Chemo-Immunotherapy at RomeLung25
Domenico Galetta, Medical oncologist at IRCCS Giovanni Paolo II, shared a post on X: "Very…
May 11, 2025, 13:57 | Science
Giannis Mountzios: Shedding Light on Factors Influencing Treatment Sequence in BRAF Mutant NSCLC
Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant…
May 11, 2025, 07:48 | Cancer Types
Meningioma: Types, Symptoms, Diagnosis, Treatment, Malignancy Risk, and 2025 Breakthroughs
This article offers a comprehensive overview of meningioma, the most common primary brain tumor in…
May 11, 2025, 06:52 | Blog
PSOGI Explores Evolving Approaches to MSI-H Colorectal Peritoneal Metastases in Case of the Month
Peritoneal Surface Oncology Group International (PSOGI) posted on X: "CASE OF THE MONTH 40 Summarized…
May 9, 2025, 12:42 | Drugs
Penpulimab: What patients need to know?
Penpulimab, also known by its generic name penpulimab-kcqx, is a newly FDA-approved immunotherapy for certain…
May 9, 2025, 11:44 | Blog
Susanna Fletcher Greer: A Surprising Immune Cell that could reshape how we Monitor and Mobilize Anti-Tumor Immunity
Susanna Fletcher Greer, Chief Scientific Officer at the V Foundation, shared a post on LinkedIn: "Hidden…
May 9, 2025, 09:15 | Drugs
Penpulimab: Uses in Cancer, Side Effects, Dosage, Expectations, and More
​Penpulimab is a novel humanized monoclonal antibody that targets PD-1 (programmed death-1), a key immune…
May 8, 2025, 18:00 | Career
E. John Wherry elected to National Academy of Sciences for cancer immunotherapy research
Parker Institute for Cancer Immunotherapy shared a post on X: "Congrats to E. John Wherry,…
May 8, 2025, 11:47 | Blog
The Official Launch of the International Summit in Immuno-Oncology - Santé Arménie Medical Academy
Santé Arménie Medical Academy shared a post on LinkedIn: "We are thrilled to announce the official…
May 7, 2025, 09:26 | Science
Aaron Hansen: New Chemotherapy Database to Monitor Ovarian Cancer Treatment in New Zealand
Aaron Hansen, Acting Medical Director Cancer Services at Princess Alexandra Hospital, shared an article on LinkedIn:…
May 5, 2025, 16:04 | Blog
Immunotherapy with Chemoradiotherapy Reduces Surgical Need in Rectal Cancer - ESTRO
European Society for Radiotherapy and Oncology (ESTRO) shared a post on LinkedIn: "ESTRO25 Press release.…
May 4, 2025, 01:51 | Blog
AACR25 Clinical Trials plenary highlights advances in expanding Immunotherapy access
AACR shared a post on X: "Clinical Trials Plenary Session: Advances in Immunotherapy — Researchers presented…
May 3, 2025, 21:10 | Blog
Douglas Flora Highlights MSKCC Immunotherapy Trial for MMRd Tumors at AACR 2025
Douglas Flora, President-Elect at Association of Cancer Care Centers, shared on LinkedIn: "Significant Findings Presented…
May 2, 2025, 18:25 | Science
LOXHD1 Identified as Immunotherapy Target in Ewing Sarcoma - Parker Institute for Cancer Immunotherapy
Parker Institute for Cancer Immunotherapy shared a post on X: "Few cancers rob young lives…
May 2, 2025, 16:17 | Blog
Myriam Chalabi Discusses Neoadjuvant Immunotherapy and NEOASIS Study Findings at AACR25 - Agenus
Agenus shared a post on LinkedIn: "Yesterday at AACR25, Dr. Myriam Chalabi participated in the…
May 2, 2025, 10:51 | Blog
Beau Bosko Toskich: Combining Local Therapy and Immunotherapy in Intermediate Stage HCC
Beau Bosko Toskich, Professor of Radiology and Director of Interventional Oncology at Mayo Clinic Florida,…
May 2, 2025, 10:21 | Blog
AACR 2025 in Focus: Top Highlights from the Annual Meeting
Every year, the AACR Annual Meeting brings together the global cancer research community—and every year,…
All: 838 Posts: 1 - 100
Special Coverage